![PRD_900113 PRD_900113](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900113.svg) | PRD_900113 | Name: | GALACTOBIOSE | Formula: | C12 H22 O11 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900114 PRD_900114](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900114.svg) | PRD_900114 | Name: | GALACTOTRIOSE | Formula: | C18 H32 O16 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900115 PRD_900115](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900115.svg) | PRD_900115 | Name: | MANNOBIOSE | Formula: | C12 H22 O11 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900116 PRD_900116](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900116.svg) | PRD_900116 | Name: | 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose | Formula: | C10 H18 O9 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900117 PRD_900117](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900117.svg) | PRD_900117 | Name: | beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranosyl-(1->4)-beta-D-xylopyranose | Formula: | C15 H26 O13 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900118 PRD_900118](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900118.svg) | PRD_900118 | Name: | 6-O-alpha-D-mannopyranosyl-alpha-D-mannopyranose | Formula: | C12 H22 O11 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900119 PRD_900119](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900119.svg) | PRD_900119 | Name: | Lewis X antigen, beta anomer | Formula: | C20 H35 N O15 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900120 PRD_900120](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900120.svg) | PRD_900120 | Name: | Lewis X antigen, alpha anomer | Formula: | C20 H35 N O15 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900121 PRD_900121](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900121.svg) | PRD_900121 | Name: | Sialyl-Lewis X antigen, beta anomer | Formula: | C31 H52 N2 O23 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900122 PRD_900122](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900122.svg) | PRD_900122 | Name: | Sialyl-Lewis X antigen, alpha anomer | Formula: | C31 H52 N2 O23 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900123 PRD_900123](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900123.svg) | PRD_900123 | Name: | Lewis B antigen, beta anomer | Formula: | C26 H45 N O19 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900124 PRD_900124](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900124.svg) | PRD_900124 | Name: | Lewis Y antigen, alpha anomer | Formula: | C26 H45 N O19 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900125 PRD_900125](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900125.svg) | PRD_900125 | Name: | H type 2 antigen, alpha anomer | Formula: | C20 H35 N O15 | Description: | oligosaccharide | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900126 PRD_900126](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900126.svg) | PRD_900126 | Name: | Blood group A Lewis B antigen, beta anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900127 PRD_900127](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900127.svg) | PRD_900127 | Name: | Blood group A Lewis Y antigen, beta anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_900128 PRD_900128](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900128.svg) | PRD_900128 | Name: | Blood group A Lewis Y antigen, alpha anomer | Formula: | C34 H58 N2 O24 | Description: | oligosaccharide with branches | Definition date: | 2020-07-29 | Last modified: | 2020-07-29 |
|
![PRD_002374 PRD_002374](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002374.svg) | PRD_002374 | Name: | cyclic trypsin inhibitor | Formula: | C66 H106 N18 O18 | Definition date: | 2020-07-01 | Last modified: | 2020-07-02 |
|
![PRD_002375 PRD_002375](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002375.svg) | PRD_002375 | Name: | cyclic trypsin inhibitor | Formula: | C69 H109 N21 O18 | Definition date: | 2020-07-01 | Last modified: | 2020-07-02 |
|
![PRD_002127 PRD_002127](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002127.svg) | PRD_002127 | Name: | N-[4-(hydroxymethyl)benzoyl]-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | Formula: | C38 H54 N7 O11 P | Definition date: | 2014-12-03 | Last modified: | 2020-06-27 |
|
![PRD_002270 PRD_002270](https://data.pdbj.org/pdbjplus/data/cc/svg/9BA.svg) | PRD_002270 | Name: | N-{(3R,6S,9S,12R)-6-ethyl-12-methyl-9-[3-(N'-methylcarbamimidamido)propyl]-2,5,8,11-tetraoxo-3-phenyl-1,4,7,10-tetraazacyclotetradecan-12-yl}-2-methylpropanamide | Formula: | C28 H44 N8 O5 | Definition date: | 2017-06-28 | Last modified: | 2020-06-21 |
|
![PRD_002393 PRD_002393](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002393.svg) | PRD_002393 | Name: | UAW247 | Formula: | C24 H27 N3 O5 | Definition date: | 2020-06-17 | Last modified: | 2020-06-17 |
|
![PRD_002385 PRD_002385](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002385.svg) | PRD_002385 | Name: | Papain-like protease peptide inhibitor VIR250 | Formula: | C23 H32 N6 O6 S | Definition date: | 2020-05-20 | Last modified: | 2020-05-20 |
|
![PRD_001136 PRD_001136](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_001136.svg) | PRD_001136 | Name: | SUGAR (6-MER) | Formula: | C57 H82 O26 | Description: | Chromomycin A3 is an anthraquinone. It is a glycosidic antibiotic produced at the fermentation of a strain of Streptomyces griseus. It is also called toyomycin. | Definition date: | 2013-07-26 | Last modified: | 2020-04-04 |
|
![PRD_002326 PRD_002326](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002326.svg) | PRD_002326 | Name: | Phosphinic inhibitor DG014 | Formula: | C62 H91 N9 O18 P | Definition date: | 2019-12-18 | Last modified: | 2019-12-18 |
|
![PRD_002357 PRD_002357](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002357.svg) | PRD_002357 | Name: | SHV-WFP-SER-PRO-YCP-ALA-MP8 Acyldepsipeptide | Formula: | C39 H54 F2 N6 O8 | Definition date: | 2019-11-06 | Last modified: | 2019-11-06 |
|